Press Release

UAE Insulin Pumps Market to grow with a CAGR of 15.54%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Insulin Pumps Market.

 

According to TechSci Research report, “UAE Insulin Pumps Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Insulin Pumps Market has valued at USD 49.90 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 15.54% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market. Improved access to healthcare is a key factor that can drive the demand for insulin pumps. Improved access to healthcare services enables individuals to receive early diagnosis and intervention for diabetes. In cases where insulin pump therapy is deemed necessary, timely access to healthcare facilities ensures that patients can start using insulin pumps at an early stage of their condition. Healthcare facilities that specialize in diabetes care, such as endocrinology clinics and diabetes centers, are better equipped to provide comprehensive management solutions, including insulin pump therapy. Improved access to these specialized services can increase the availability of insulin pumps for patients who may benefit from them. Access to trained healthcare professionals, such as endocrinologists, diabetes educators, and specialized nurses, is crucial for the successful implementation of insulin pump therapy. Improved access ensures that patients receive proper guidance, training, and ongoing support from knowledgeable professionals.

Access to healthcare facilitates educational initiatives on diabetes management, including the benefits of insulin pumps. Healthcare providers can disseminate information about insulin pump therapy, leading to greater awareness and potentially increased demand among patients who were previously unaware of this treatment option. Improved access to healthcare often involves efforts to enhance insurance coverage and reimbursement policies for medical devices, including insulin pumps. When patients have better financial support for acquiring insulin pumps, it can significantly boost the demand for these devices. Geographic and economic barriers to healthcare can be significant obstacles for some individuals. Improved access may involve efforts to reduce these barriers, making it easier for patients to reach healthcare facilities where they can receive information about and access insulin pumps.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Insulin Pumps Market.”

 

In February 2023, GulfDrug LLC, EOFlow Co.'s partner in the Gulf region, has introduced the tubeless, disposable insulin pump "EOPatch" in the United Arab Emirates (UAE). Starting from February 2023, residents in the UAE can manage insulin infusions directly from their Android and iOS smartphones through the newly launched Narsha app. This marks the first entry of EOPatches in the Middle East, establishing the UAE as EOFlow's second overseas sales region, following Europe. The launch is seen as a strategic move, serving as a gateway for exporting wearable insulin pump solutions to Middle East and North Africa (MENA) countries. GulfDrug is actively preparing to extend its presence to other Gulf countries and plans to seek approval and registration for EOPatch in Saudi Arabia, the largest diabetes market in the Gulf Cooperation Council (GCC) countries. EOFlow and GulfDrug are committed to expanding their market presence in the Gulf region, given the significant diabetes population in the area. EOPatch is notable as one of the two fully disposable, wearable insulin pump solutions currently available worldwide.

Data privacy concerns are a significant challenge in the UAE insulin pumps market, as in many other healthcare technology sectors. Insulin pumps, especially those integrated with digital health platforms, collect and store sensitive health information, including real-time glucose levels and insulin dosages. The protection of this highly personal data is paramount to maintain patient trust. The UAE, like many other countries, has regulations and standards governing the protection of healthcare data. Ensuring compliance with these regulations, such as the Health Data Protection Law, is essential but can be challenging due to the evolving nature of digital health technologies. The interconnected nature of digital health devices, including insulin pumps, makes them susceptible to cybersecurity threats. Unauthorized access to patient data can lead to privacy breaches, identity theft, and other malicious activities. Patients may be hesitant to adopt insulin pumps if they are concerned about the confidentiality of their health information. The fear of unauthorized access to personal health data can create barriers to adoption.

UAE Insulin Pumps Market is segmented based on Type, Insulin Used, Application, End User, and by region.

Based on the Type, UAE Insulin Pumps Market is segmented into Traditional Insulin Pumps, Patch Pumps. Traditional insulin pumps, also known as conventional insulin pumps, are medical devices designed to deliver a continuous and precise supply of insulin to individuals with diabetes. These pumps provide an alternative to multiple daily injections, offering a more automated and controlled approach to insulin delivery. Traditional insulin pumps deliver a continuous and low-level supply of insulin throughout the day and night. This background insulin, known as the basal rate, mimics the natural secretion of insulin by the pancreas and helps maintain stable blood glucose levels between meals and during periods of fasting. In addition to basal insulin, traditional insulin pumps allow users to administer additional insulin as needed. This additional insulin, known as a bolus, is delivered to cover meals or correct high blood glucose levels. Users manually input the bolus amount based on factors such as carbohydrate intake and current blood glucose levels.

Based on Region, Abu Dhabi region held the largest share in the UAE Insulin Pumps Market. Economic factors, such as higher income levels in Abu Dhabi, could influence the affordability and accessibility of insulin pumps. Patients in regions with higher income levels may be more likely to afford these devices. Abu Dhabi is a hub for medical research and innovation, it could attract companies and professionals working on the development and promotion of advanced diabetes management technologies, including insulin pumps. The prevalence of diabetes in a region's population could also impact the demand for insulin pumps. If the Abu Dhabi population has a higher incidence of diabetes, there may be a greater need for advanced diabetes management solutions.

 

Some of the major companies operating in the UAE Insulin Pumps Market include:

  • Medtronic Meta FZ-LLC
  • Roche UAE
  • Abbott Laboratories, S.A.
  • Nipro Middle East FZE
  • B. Braun Medical Gulf Fz-LLC
  • Terumo Middle East FZE
  • Becton, Dickinson, and Company

 

Download Free Sample Report

Customers can also request 10% free customization on this report.

 

“Certain areas, particularly in Dubai, are projected to exert significant demand for Insulin Pumps. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Insulin Pumps Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Insulin Pumps Market by Type (Traditional Insulin Pumps, Patch Pumps), By Insulin Used (Short Acting Insulin, Rapid Acting Insulin), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Insulin Pumps Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Insulin Pumps Market.


Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com

Relevant News